Apixaban
Therapeutic Category
- Anti-coagulant
Innovator Brand
GMP
DMF
Filed
Under Filing
Sample
Indication
Apixaban with CAS# 503612-47-3 known with Brand Name (Eliquis). is a factor xa inhibitor indicated:It is used to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.
For the prophylaxis of deep vein thrombosis (dvt), which may lead to pulmonary embolism (pe), in patients who have undergone hip or knee replacement surgery.
For the treatment of dvt and pe, and for the reduction in the risk of recurrent dvt and pe following initial therapy.
CTX Lifesciences, is one of the leading Active Pharmaceutical Ingredients ( API ) manufacturer and supplier globally for Apixaban with CAS# 503612-47-3 from India. We are a leading exporter of Apixaban API with CAS# 503612-47-3. We are a trusted supplier with API exports in more than 87 Countries including the US, Europe, Brazil, Latin America, China, Korea,Iran, Middle East and other emerging markets.
CTX Lifesciences is one of the leading manufacturer & supplier of Apixaban with CAS# 503612-47-3 from India. This product is provided from our GMP compliant plant with product made under complete cGMP conditions. We provided with documentation support & Drug Master File(DMF). Our manufacturing plant at Surat has accreditation by US-FDA, EDQM , EMA , ANVISA, KFDA, MOH IRAN, Health Canada & Russian Authorities.
CTX Lifesciences also offer other anticoagulants agents such as direct thrombin inhibitor Dabigatran Etexilate Mesylate and other direct factor Xa inhibitor Edoxaban Tosylate Monohydrate.
Disclaimer: CTX Lifesciences respects patent laws and conventions of pharmaceuticals as applicable in different countries.
API/Substances covered by patent are not offered to the countries where the patent law is in force. However, the final responsibility lies with the customer.